Beigene (06160) opened up nearly 4%, as of press time, up 3.70%, at HKD 96.60, with a turnover of HKD 6.5371 million.
According to the Cnstock APP, Beigene (06160) opened up nearly 4%, as of press time, up 3.70%, at HKD 96.60, with a turnover of HKD 6.5371 million.
On the news side, Beigene announced that its new flagship base located in the Hopewell-West Innovation Park in Princeton, New Jersey, USA was officially launched yesterday (23rd).
According to Beigene, the base covers an area of about 0.17 million square meters, with an investment of 0.8 billion US dollars and a construction period of three years, equipped with world-class biologic production capacity and clinical research and development centers. It is expected to help enhance the company's differentiation competitiveness as a tumor treatment innovation company, and provide flexibility for the scale production of existing and future innovative drugs. The exclusive commercial biopharmaceutical production area covers approximately 0.037 million square meters, with reserved space for future expansion.
Co-founder, director and CEO John Oyler said that in the future, the company will deepen its relationship with major regional research institutions to advance the next generation of hematology and solid tumor drug pipelines.